These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32993820)

  • 1. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
    Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and severity-of-illness risk adjustment for hospital-onset
    Cabral SM; Goodman KE; Blanco N; Leekha S; Magder LS; Nadimpalli G; Pineles L; Thom KA; Harris AD
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):955-961. PubMed ID: 33327970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.
    Murphy CR; Avery TR; Dubberke ER; Huang SS
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse Work Environment and Hospital-Onset Clostridioides difficile Infection.
    Jung OS; Aiken LH; Sloane DM; Fridkin SK; Li Y; Kang YJ; Becker ER; Joski PJ; Cimiotti JP
    Med Care; 2023 Jun; 61(6):360-365. PubMed ID: 37167557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating hospital-onset
    Carling PC; O'Hara LM; Harris AD; Olmsted R
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):440-446. PubMed ID: 35718355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treated, hospital-onset
    Yu KC; Ye G; Edwards JR; Dantes R; Gupta V; Ai C; Betz K; Benin AL
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):48-56. PubMed ID: 37449415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?
    Ricciardi R; Nelson J; Griffith JL; Concannon TW
    J Hosp Infect; 2012 Feb; 80(2):156-61. PubMed ID: 22137065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal change of risk factors in hospital-acquired
    Song J; Cohen B; Zachariah P; Liu J; Larson EL
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides difficile infections in Alberta: The validity of administrative data using ICD-10 diagnostic codes for CDI surveillance versus clinical infection surveillance.
    Pfister T; Rennert-May E; Ellison J; Bush K; Leal J
    Am J Infect Control; 2020 Dec; 48(12):1431-1436. PubMed ID: 32810568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-acquired Clostridioides difficile infections in Alberta: The validity of laboratory-identified event surveillance versus clinical infection surveillance.
    Almond J; Leal J; Bush K; Rogers E; Henderson EA; Ellison J
    Am J Infect Control; 2020 Jun; 48(6):633-637. PubMed ID: 31733811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility-onset,
    Puri S; Hughes HY; McCrackin MD; Williford R; Gebregziabher M; Salgado CD; Curry SR
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):467-468. PubMed ID: 31973777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-Discharge
    Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.